AI assistant
FASTENAL CO — Director's Dealing 2024
Oct 18, 2024
29988_dirs_2024-10-18_51dd8951-ee50-4157-9c69-547a795a38a6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3/A — Form 3/A
Issuer: FASTENAL CO (FAST)
CIK: 0000815556
Period of Report: 2023-10-11
Reporting Person: Broersma Anthony Paul (N/A)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 6100 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) | $23 | 2025-05-31 | Common Stock (680) | Direct | |
| Employee Stock Option (Right to Buy) | $23.50 | 2026-12-31 | Common Stock (6382) | Direct | |
| Employee Stock Option (Right to Buy) | $27.50 | 2027-12-31 | Common Stock (5454) | Direct | |
| Employee Stock Option (Right to Buy | $26 | 2028-12-31 | Common Stock (5768) | Direct | |
| Employee Stock Option (Right to Buy) | $38 | 2029-12-31 | Common Stock (3947) | Direct | |
| Employee Stock Option (Right to Buy) | $48 | 2030-12-31 | Common Stock (3125) | Direct | |
| Employee Stock Option (Right to Buy) | $62 | 2031-12-31 | Common Stock (2419) | Direct | |
| Employee Stock Option (Right to Buy) | $48 | 2032-12-31 | Common Stock (3125) | Direct |
Footnotes
F1: The option will fully vest and become exercisable over a period of eight years, with 50% vesting and becoming exercisable two years following the date of grant and the remainder vesting and becoming exercisable proportionately (12.5%) each year thereafter.
F2: The Form 3 filed for the reporting person on 10/23/2023 incorrectly stated 5,434 securities and the correct number of securities is 680.
F3: The option will fully vest and become exercisable over a period of eight years, with 25% vesting and becoming exercisable two years following the date of grant and the remainder vesting and becoming exercisable proportionately (12.5%) each year thereafter.
F4: The option will fully vest and become exercisable over a period of eight years, with 40% vesting and becoming exercisable two years following the date of grant and the remainder vesting and becoming exercisable proportionately (20%) each year thereafter.
F5: The option will fully vest and become exercisable over a period of five years, with 40% vesting and becoming exercisable two years following the date of grant and the remainder vesting and becoming exercisable proportionately (20%) each year thereafter.